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The data are related to the proteomic analysis of 43 newborns with
intrauterine growth retardation (IUGR) and 45 newborns with
appropriate weight for gestational age (AGA) carried out by
separation via 2DE and analyzed by MS–TOF/TOF. All newborns
were separated into three gestational age groups, "Very Preterm"
29–32 weeks, "Moderate Preterm" 33–36 weeks, and, "Term"
Z37weeks. From each newborn, blood was drawn three times
from birth to 1 month life. High-abundant serum proteins were
depleted, and the minority ones were separated by 2DE and ana-
lyzed for signiﬁcant expression differences. The data reﬂect ana-
lytic and clinic variables analyzed globally and categorized by
gestational age in relation to IUGR and the optimization of con-
ditions for 2-DE separation. The data from this study are related to
the research article entitled "Alterations of Protein Expression in
Serum of Infants with Intrauterine Growth Restriction andvier Inc. This is an open access article under the CC BY license











M.D. Ruiz-González et al. / Data in Brief 9 (2016) 438–447 439Different Gestational Ages" (M.D. Ruis-González, M.D. Cañete, J.L.
Gómez-Chaparro, N. Abril, R. Cañete, J. López-Barea, 2015) [1]. The
present dataset of serum IUGR newborn proteome can be used as a
reference for any study involving intrauterine growth restriction
during the ﬁrst month of life.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc
subject areaNeonatology, IUGR (intrauterine growth restriction)ype of data Tables and ﬁgures
ow data was
acquiredBy clinical history and 2-DE gel PAGEata format Analysed
xperimental
factorsSamples were subjected to protein depletion using the ProteominerTM kit (Bio-
Rad
s
) prior to separation by 2-DE electrophoresis
xperimental
featuresStandard procedures of laboratory and 2-DE gels electrophoresisata source
locationCórdoba (Spain)ata accessibility The data are supplied with this articleValue of the data
 The clinical characteristics of IUGR neonates, and the statistical analysis of quantitative and qua-
litative variables, carried out both globally and in function of gestational age can be useful for other
scientists working in the IUGR ﬁeld.
 The set-up and optimization of the conditions of 2-DE analysis in sera from newborns could be
useful for the reproducibility of similar future trials.
 This dataset could be used as a benchmark for studies on the variations of serum proteomic IUGR
from birth through the ﬁrst month of life.1. Data
Descriptive analysis of analytical and clinical variables was carried out globally (Tables 1–3) and
categorized also according to gestational age (GA) groups in “Very Preterm”, “Moderate Preterm” and
“Term” IUGR infants at different times after birth (0–48 h, 7–10d, 28–30d) (Tables 4–6). Table 7
illustrates the pathogenic microorganisms isolated in positive hemocultures.
For the development of 2-DE electrophoresis, we started carrying our 2-DE gels with a wide pH
range (3–10), as shown in Fig. 1A. In these initial gels we observed that most of the proteins were in
the pH range 4–7. Thus, we reasoned that the resolution would improve using IPG strips of narrower
pH gradient. Thus, 2-DE electrophoresis was routinely carried out using IPG strips of 11 cm and pH
range 4–7, as shown in Fig. 1B. Isoelectric focusing was performed using an Protean IEF Cell (BioRad) a
20 °C according the next program (Table 8).
Table 1
Global analysis of qualitative variables analyzed in IUGR neonates.
Variable Infant type N n (%) P value
Respiratory dystres IUGR 43 13 (30.2) 0.171
AGA 45 8 (17.8)
NEC IUGR 43 2 (4.7) 0.143
AGA 45 0
Hypoxia-ischemia IUGR 43 0 NA
AGA 45 0
Hypoglycemia 0–48 h IUGR 43 13 (30.2) 0.171
AGA 45 8 (17.8)
Hypoglycemia 7–10d IUGR 43 1 (2.3) 0.974
AGA 45 1 (2.2)
Primiparae IUGR 43 30 (69.8) 0.166
AGA 45 30 (66.7)
Prenatal corticosteroids IUGR 43 22 (51.2) 0.839
AGA 45 24 (53.3)
Preeclampsia IUGR 43 13 (30.2) n0.001
AGA 45 2 (4.4)
Pregnancy-induced hypertension IUGR 43 6 (13.9) n0.001
AGA 45 1 (2.2)
Oligohydramnios IUGR 43 3 (7.0) 0.079
AGA 45 0
Thrombocytopenia 0–48 h IUGR 43 8 (18.6) n0.002
AGA 45 0
Thrombocytopenia 7–10d IUGR 43 4 (9.3) n0.036
AGA 45 0
Thrombocytopenia 28–30d IUGR 43 2 (4.7) 0.143
AGA 45 0
Hemocultive þ 0–48 h IUGR 43 1 (2.3) 0.328
AGA 45 3 (6.7)
Hemocultive þ 7–10d IUGR 43 11 (25.6) n0.005
AGA 45 2 (4.4)
Hemocultive þ 28–30d IUGR 43 2 (4.7) 0.143
AGA 45 0
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Table 1 (continued )
Variable Infant type N n (%) P value
Polycythaemia 0–48 h IUGR 43 2 (4.7) 0.143
AGA 45 0
Smoking IUGR 43 1 (2.3) 0.304
AGA 45 0
Alcohol/other drugs IUGR 43 0 NA
AGA 45 0
IUGR. intrauterine growth restriction; AGA. appropriate for gestational age; NEC. necrotizing enterocolitis; NA. not applicable
n signiﬁcant (p o 0.05)
Table 2
Global analysis of qualitative variables (16) analyzed in IUGR neonates of the three gestational age groups.
Variable Infant
type
N Group 1 (GA 29
a 32w)
P N Group 2 (GA 33
a 36w)
P N Group 3 (GA
Z 37 w)
P
Respiratory dystres IUGR 13 6 (46.15) 0.488 15 4 (26.66) 0.142 15 3 (20.00) 0.624
AGA 15 5 (33.33) 15 1 (06.66) 15 2 (13.00)
NEC IUGR 13 – NA 15 2 (13.00) 0.143 15 – NA
AGA 15 – 15 0 15 –
Hypoxia-Ischemia IUGR 13 – NA 15 – NA 15 – NA
AGA 15 – 15 – 15 –
Hypoglycemia 0–
48 h
IUGR 13 2 (15.38) 0.150 15 3 (20.00) 0.624 15 8 (53.33) n0.001
AGA 15 6 15 2 (13.00) 15 0
Hypoglycemia 7–
10d
IUGR 13 – NA 15 1 (06.66) 0.974 15 – NA
AGA 15 – 15 1 (06.66) 15 –
Primiparae IUGR 13 9 (69.23) 0.229 15 9 (60.00) 0.512 15 12 (80.00) 0.512
AGA 15 7 (46.66) 15 10 (66.7) 15 13 (86.6)
Prenatal
corticosteroids
IUGR 13 12 (92.3) 0.630 15 9 (60.00) 0.439 15 1 (06.66) 0.309
AGA 15 13 (86.7) 15 11 (73.3) 15 0
Preeclampsia IUGR 13 6 (46.15) 0.055 15 7 (46.66) n0.003 15 – NA
AGA 15 2 (13.33) 15 0 15 –
PIH IUGR 13 3 (23.07) 0.216 15 1 (06.66) 0.309 15 2 (13.33) 0.143
AGA 15 1 (06.66) 15 0 15 0
Oligohydramnios IUGR 13 2 (07.69) 0.115 15 – NA 15 1 (06.66) 0.309
AGA 15 0 15 – 15 0
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Table 2 (continued )
Variable Infant
type
N Group 1 (GA 29
a 32w)
P N Group 2 (GA 33
a 36w)





IUGR 13 2 (07.69) 0.115 15 5 (33.33) n0.014 15 1 (06.66) 0.309
AGA 15 0 15 0 15 0
Thrombocytopenia
7–10d
IUGR 13 1 (07.69) 0.274 15 2 (13.33) 0.143 15 1 (07.69) 0.309
AGA 15 0 15 0 15 0
Thrombocytopenia
28–10d
IUGR 13 – NA 15 1 (07.69) 0.309 15 – NA
AGA 15 – 15 0 15 –
Hemocultive þ 7–
10d
IUGR 13 7 (53.84) n0.022 15 4 (26.66) n0.032 15 – NA
AGA 15 2 (13.33) 15 0 15 –
Polycythaemia 0–
48 h
IUGR 13 – NA 15 1 0309 15 0.309
AGA 15 – 15 0 15 0
Smoking IUGR 13 1 (07.69) 0.274 15 – NA 15 – NA
AGA 15 0 15 – 15 –
IUGR. intrauterine growth restriction; AGA. appropriate for gestational age; NEC. necrotizing enterocolitis; PIH. pregnancy-
induced hypertension; NA. not applicable.
n signiﬁcant (p o 0.05).
Table 3




Sampling time 0–48 h Sampling time 7–10 days Sampling time 28–30 days
N Value P N Value P N Value P
RCP (mg/L) IUGR 40 01.3972.78 n0.017 33 07.00717.3 0.313 18 06.92714.7 0.052
AGA 39 12.2572.79 37 03.57710.3 25 01.2172.28
PCT (ng/mL) IUGR 8 00.2170.21 0.263 14 01.7073.10 0.316 3 04.7277.00 0.624
AGA 19 09.2572.20 6 00.3670.47 1 0.08————
Hb (g/dL) IUGR 43 18.1572.02 no0.001 40 15.7272.45 n0.009 37 10.8871.84 0.528
AGA 45 15.5772.13 41 14.1972.62 42 10.5672.01
Hto (%) IUGR 43 54.3976.33 no0.001 40 47.6677.36 n0.008 38 32.0275.19 0.814
AGA 45 47.9075.95 41 42.9978.13 42 31.7176.15
Leukocytes
(103/lL)
IUGR 43 13,41677659 0.151 40 12,18474253 0.543 39 10,80473305 0.569
AGA 45 21,03673327 41 12,84975465 42 11,22473298
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Table 3 (continued )
Variable Infant
type
Sampling time 0–48 h Sampling time 7–10 days Sampling time 28–30 days
N Value P N Value P N Value P
Neutrophils (%) IUGR 43 49.67715.5 0.558 40 35.33712.0 n0.018 38 23.8878.39 0.502
AGA 45 51.64715.6 41 41.58711.3 42 25.1478.39
Lymphocyte (%) IUGR 43 39.41715.1 0.204 40 43.63712.3 0.202 39 55.57710.0 0.222
AGA 45 35.34714.3 41 40.23711.5 41 58.24719.3
Monocytes (%) IUGR 43 07.5673.81 0.129 40 14.7575.38 n0.037 39 09.3172.58 0.595
AGA 45 08.9474.44 41 12.3274.91 42 08.9673.27
Eosinophils (%) IUGR 43 02.4671.88 0.785 40 04.3472.93 0.719 39 06.9275.05 0.111
AGA 45 02.3671.59 41 04.1471.92 42 05.4073.34
Basophils (%) IUGR 43 00.8470.55 0.196 40 01.3770.80 0.110 36 00.8970.46 0.442
















AST (U/L) IUGR 30 70.00786.0 0.814 34 35.00718.0 0.428 37 35.0740.0 0.402
AGA 26 66.00744.0 37 31.00714.0 37 30.0712.0
ALT (U/L) IUGR 30 25.00748.0 0.959 32 14.00717.0 0.410 25 18.075.00 0.052
AGA 26 26.00749.0 37 19.00726.0 24 20.079.00
Glucose (mg/
dL)
IUGR 42 51.00732.0 0.525 40 79.00726.0 0.399 42 81.00718.0 0.534
AGA 44 52.0736.0 44 84.00724.0 43 78.00712.0
Protein (g/L) IUGR 43 05.0070.75 0.524 39 05.2070.55 0.199 42 04.6870.85 0.191
AGA 45 05.1071.06 44 05.3970.76 44 04.9070.65
K (mEq/L) IUGR 42 04.5970.81 0.532 39 04.8070.78 0.674 40 05.2870.69 0.813
AGA 43 04.7070.78 44 04.7270.78 44 05.2570.65
Na (mEq/L) IUGR 45 135.073.29 0.171 40 135.673.76 0.183 41 136.272.33 0.899
AGA 45 136.273.29 44 136.673.31 44 136.173.33
Ca (mg/dL) IUGR 40 10.2670.88 0.239 39 11.1470.57 0.259 31 11.0070.80 0.051
AGA 41 10.0270.93 43 11.0070.54 39 11.3270.50
Urea (mg/dL) IUGR 43 24.65713.93 0.421 40 18.15714.1 0.634 42 13.8079.13 0.776
AGA 41 26.90711.40 44 19.61714.8 44 13.3176.60
Cre (mg/dL) IUGR 42 00.6970.19 0.449 40 00.4870.14 0.473 41 00.3870.06 0.511
AGA 40 00.7370.26 45 00.5170.12 44 00.3770.07
IUGR. intrauterine growth restriction; AGA. appropriate for gestational age; RCP. reactive C protein; PCT. procalcitonin; Hb.
hemoglobin; AST. aspartate aminotransferase; K. potassium; Na. sodium; Cre. creatinine.
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Table 4
Descriptive analysis categorized according to the gestational ages of quantitative variables of "Very Preterm" IUGR neonates at
different times after birth.
Group 1 (GA 29 to 32w)
Variable Infant
type
N 0-48h P N 7–10d P N 28–30d P
RCP (mg/L) IUGR 13 00.9371.40 0.279 13 11.09722.1 0.493 11 06.95711.5 0.468
AGA 12 04.19710.5 13 05.66717.3 7 02.1873.72
Hb (g/dl) IUGR 13 17.3671.66 n0.012 13 14.1772.55 0.265 11 10.6071.93 0.588
AGA 15 15.6771.64 13 13.0472.49 14 10.2271.93
Hto (%) IUGR 13 51.6675.49 n0.028 13 42.8077.82 0.157 11 31.8675.24 0.647
















PMN (%) IUGR 13 34.40710.4 0.498 13 38.01716.4 0.231 12 24.01710.3 0.816
AGA 15 38.38712.2 13 45.50714.6 14 24.8277.16
Monocytes (%) IUGR 13 08.7175.61 0.434 13 18.1677.36 n0.008 12 09.1572.33 0.392
AGA 15 10.6276.73 13 10.8975.40 11 09.9472.23
GA: gestational age; IUGR: intrauterine growth restriction; RCP: reactive C protein; Hb: hemoglobin; Hto: Hematocrit; PMN:
polymorphonuclears.
n signiﬁcant (p o 0.05)
Table 5
Descriptive analysis categorized according to the gestational ages of quantitative variables of "Moderate Preterm" IUGR neo-
nates at different times after birth.
Group 2 (GA 33 to 36w)
Variable Infant
type
N 0-48h P N 7–10d P N 28–30d P
RCP (mg/L) IUGR 15 01.9474.11 0.157 9 08.36719.65 0.203 5 09.54711.23 0.115
AGA 13 00.2670.28 11 00.5870.79 6 01.4172.29
Hb (g/dl) IUGR 15 18.2671.98 n0.001 12 16.0971.84 n0.003 12 10.5971.99 0.112
AGA 15 15.1372.19 14 13.4772.19 14 09.4171.87
Hto (%) IUGR 15 54.2476.07 n0.002 12 48.6375.27 n0.001 15 30.9275.75 0.275
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Table 5 (continued )
Group 2 (GA 33 to 36w)
Variable Infant
type
N 0-48h P N 7–10d P N 28–30d P
Neutrophils
(%)
IUGR 15 50.06712.66 0.681 12 34.65712.07 0.230 14 25.0379.08 0.316
AGA 15 51.18712.17 14 39.4477.51 14 28.6679.70
Monocytes (%) IUGR 15 06.7272.55 0.683 12 12.3172.50 0.458 15 08.2072.06 0.620
AGA 15 07.1072.28 14 13.1273.29 15 08.8173.70
GA: gestational age; IUGR: intrauterine growth restriction; RCP: reactive C protein; Hb: hemoglobin; Hto: Hematocrit
n signiﬁcant (p o 0.05)
Table 6
Descriptive analysis categorized according to the gestational ages of quantitative variables of "Term" IUGR neonates at different
times after birth.
Group 3 (GA Z 37s w)
Variable Infant
type
N 0–48 h P N 7–10d P N 28–30d P
RCP (mg/L) IUGR 12 01.1971.69 n0.021 11 01.0671.93 n0.009 2 00.2071.93 0.493
AGA 14 30.2074.48 13 04.0272.92 12 00.5472.92
Hb (g/dl) IUGR 14 18.7672.26 n0.002 15 16.7872.24 0.439 11 11.4271.55 0.351
AGA 15 15.92 72.25 13 16.1172.21 14 12.0671.73
Hto (%) IUGR 14 57.1276.57 n0007 15 51.0976.43 0.634 12 33.5374.39 0.264


















IUGR 14 62.52710.4 0.434 14 33.5476.80 0.060 12 22.4075.34 0.861
AGA 15 65.3878.98 15 40.10710.9 14 21.9577.23
Monocytes (%) IUGR 14 06.7272.55 0.683 15 12.3172.50 0.458 15 08.2072.06 0.620
AGA 15 07.1072.28 14 13.1273.29 14 08.8173.29
GA: gestational age; IUGR: intrauterine growth restriction; RPC: reactive C protein; Hb: hemoglobin; Hto: Hematocrit.
n signiﬁcant (p o 0.05)
M.D. Ruiz-González et al. / Data in Brief 9 (2016) 438–447 4452. Experimental design, materials and methods
2.1. Subject selection
We included IUGR neonates, deﬁned by having a birth weight o10th centile for gestational age
(GA), according to Carrascosa curves [2], together with echographic evidence of altered placental
function, identiﬁed as an abnormal Doppler of the umbilical artery, or reduced growth rate [3]. Also
Table 7











Fig. 1. Representative gels obtained for optimization of 2DE separation of high-abundance depleted human serum proteins via
IEF with IPG Strips (11 cm) of pH 3–10 (A) or pH 4–7 (B).
Table 8
IEF program conducted Protean IEF Cell system (Bio-Rad).
Stage Voltage (V) Duration (hours:minutes) Ramp
Passive rehydration – 6:00 –
Active rehydration 50 6:00 Rapid
Phase 1 500 1:00 Lineal
Phase 2 1.000 1:00 Lineal
Phase 3 3.000 1:00 Lineal
Phase 4 6.000 2:00 Lineal
Phase 5 6.000 1:00 Rapid
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M.D. Ruiz-González et al. / Data in Brief 9 (2016) 438–447 447included were 45 infants with a birth weight appropriate for their gestational age (AGA), paired for
sex and classiﬁed in 3 groups by their GA [1].
2.2. Statistical analysis
The descriptive analysis of the variables studied was carried out with the routine methodology. Com-
parison of variables between the RCIU and AGA groups was carried out using the Student t-test for
quantitative variables and the χ2-test for qualitative variables. The Fisher exact test was applied when
conditions of applicability of the χ2-test were not fulﬁlled. A value of po0.05 was established as statistically
signiﬁcant. The R statistical software, version 3.22, was used throughout the whole study [4].Acknowledgments
This study was sponsored by PFIZER SA (grant number 12010081), Spanish Society of Neonatology
(SEN) (grant number 09122010) and Andalusian Plan for Research, Development and Innovation
(PAIDI) (grant number CTS 2329), CTS 329 group. The authors thank the Neonatology Unit staff
members of Reina Sofía University Hospital; the Department of Biochemistry and Molecular Biology
of UCO and the parents and their children who participated.Transparency document. Supporting information
Transparency data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.09.024.References
[1] M.D. Ruis-González, M.D. Cañete, J.L. Gómez-Chaparro, N. Abril, R. Cañete, J. López-Barea, Alterations of protein expression
in serum of infants with intrauterine growth restriction and different gestational ages, J. Proteom. 24 (119) (2015) 169–182.
[2] A. Carrascosa, A. Ferrández, D. Yeste, J. García-Dihinx, A. Romo, A. Copil, et al., Estudio transversal español de crecimiento
2008. Parte I: valores de peso y longitud en recién nacidos de 26-42 semanas de edad gestacional, An. Pediatr., 68, Barc
(2008) 544–551.
[3] Spanish Society of Gynaecology and Obstetrics (SEGO) (homepage on the internet). Madrid: Crecimiento intrauterino
restringido. SEGO assistance protocols in 〈http://www.sego.es〉.
[4] R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna,
Austria. URL 〈https://www.R-project.org/〉.
